About us
MatrixCell Bio is a Korean biostartup company providing solutions to regenerative and reconstructive manufacturing of tissue engineering products through mobile and stationary 3D bioprinting systems (bioinks, medical devices, and bioprinters).
Business Area
In the area of both 3D bioprinting technology and biopharma, our vision is to become the leading company in the field of regenerative medicine by contributing bioinks/hydrogels and tissue engineering equipment to the medical industry and academia. We have unique core technologies (biomaterials and equipment) for direct bioprinting in vivo and in vitro tissue engineering regenerative medicine.
Double-click to edit content. Paragraph separation (P tag) can be used with Enter, and
line breaks (BR tag) can be used with Shift + Enter.
History
2024
2023
2022
2021
Mission
Supply biomaterials and user-friendly equipment to the bioprinting tissue engineering academics and industry.
Vision
Leading bio-company in bioprinting tissue engineering and healthcare.
Core Value
1. Value creation
2. Solution to bioprinting tissue engineering problems.
3. Advanced bioprinting technology and biomaterials.
